当前位置:首页 - 行情中心 - 日科化学(300214) - 财务分析 - 利润表

日科化学

(300214)

  

流通市值:22.72亿  总市值:26.19亿
流通股本:4.04亿   总股本:4.65亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入2,414,682,357.161,428,100,103.76606,662,875.552,537,774,754.22
营业收入2,414,682,357.161,428,100,103.76606,662,875.552,537,774,754.22
二、营业总成本2,454,490,785.671,462,750,913.75611,694,418.462,442,467,461.58
营业成本2,309,964,442.21,371,377,783.07565,558,054.912,307,065,325.64
税金及附加16,906,819.3910,089,806.914,017,848.0915,284,682.6
销售费用24,908,679.3415,976,155.358,358,459.0834,199,169.2
管理费用62,197,098.0841,313,720.2925,315,513.0946,644,615.14
研发费用18,561,265.4613,976,097.036,763,408.4141,003,833.36
财务费用21,952,481.210,017,351.11,681,134.88-1,730,164.36
其中:利息费用22,917,822.9913,028,527.52,569,909.425,090,937.01
其中:利息收入623,747.21628,871.65387,426.372,949,639.75
加:公允价值变动收益000880,644.45
加:投资收益4,820,166.342,286,041.38831,355.1716,300,334.48
净敞口套期收益000-
资产处置收益186,752.54182,047.6-47,323.19-5,625,564.88
资产减值损失(新)-2,694,600.48-2,694,600.480-7,767,003.12
信用减值损失(新)-8,012,551.29-4,706,969.21-2,161,119.13-3,427,080.96
其他收益769,634.22664,492.86459,001.85837,927.74
营业利润平衡项目0000
四、营业利润-44,739,027.18-38,919,797.84-5,949,628.2196,506,550.35
加:营业外收入815,833.73658,341.07356,799.35324,355.05
减:营业外支出2,055,260.91875,099.14168,013.311,387,393.57
利润总额平衡项目0000
五、利润总额-45,978,454.36-39,136,555.91-5,760,842.1795,443,511.83
减:所得税费用8,120,403.723,062,253.942,494,560.4611,107,254.14
六、净利润-54,098,858.08-42,198,809.85-8,255,402.6384,336,257.69
持续经营净利润-54,098,858.08-42,198,809.85-8,255,402.6384,336,257.69
归属于母公司股东的净利润-52,331,549.94-42,321,071.94-8,713,724.1384,632,655.3
少数股东损益-1,767,308.14122,262.09458,321.5-296,397.61
(一)基本每股收益-0.11-0.09-0.010.18
(二)稀释每股收益-0.11-0.09-0.010.18
九、综合收益总额-54,098,858.08-42,198,809.85-8,255,402.6384,336,257.69
归属于母公司股东的综合收益总额-52,331,549.94-42,321,071.94-8,713,724.1384,632,655.3
归属于少数股东的综合收益总额-1,767,308.14122,262.09458,321.5-296,397.61
公告日期2024-10-232024-08-282024-04-272024-04-27
审计意见(境内)标准无保留意见
TOP↑